Free Trial

United-Guardian, Inc. (NASDAQ:UG) Short Interest Update

United-Guardian logo with Medical background

United-Guardian, Inc. (NASDAQ:UG - Get Free Report) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 12,000 shares, a decline of 13.0% from the December 31st total of 13,800 shares. Currently, 0.4% of the shares of the company are sold short. Based on an average daily trading volume, of 16,200 shares, the short-interest ratio is presently 0.7 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UG. Geode Capital Management LLC increased its holdings in shares of United-Guardian by 8.3% in the third quarter. Geode Capital Management LLC now owns 28,335 shares of the company's stock valued at $450,000 after purchasing an additional 2,170 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of United-Guardian by 1.1% during the second quarter. Renaissance Technologies LLC now owns 187,563 shares of the company's stock worth $1,677,000 after acquiring an additional 2,100 shares during the last quarter. Finally, Essex Investment Management Co. LLC acquired a new position in shares of United-Guardian during the third quarter valued at $126,000. Institutional investors own 23.16% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of United-Guardian in a report on Friday, January 31st. They set a "buy" rating for the company.

View Our Latest Research Report on UG

United-Guardian Stock Performance

Shares of NASDAQ:UG traded down $0.13 during midday trading on Wednesday, hitting $11.06. The company's stock had a trading volume of 13,320 shares, compared to its average volume of 7,105. The stock's 50 day simple moving average is $10.19 and its 200 day simple moving average is $11.88. The stock has a market capitalization of $50.74 million, a price-to-earnings ratio of 14.55 and a beta of 0.76. United-Guardian has a fifty-two week low of $7.02 and a fifty-two week high of $16.25.

United-Guardian (NASDAQ:UG - Get Free Report) last announced its quarterly earnings data on Friday, November 8th. The company reported $0.19 earnings per share (EPS) for the quarter. The business had revenue of $3.06 million for the quarter. United-Guardian had a net margin of 28.30% and a return on equity of 30.25%.

United-Guardian Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th will be issued a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 12.66%. The ex-dividend date of this dividend is Monday, February 10th. United-Guardian's dividend payout ratio (DPR) is presently 92.11%.

About United-Guardian

(Get Free Report)

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

See Also

Should You Invest $1,000 in United-Guardian Right Now?

Before you consider United-Guardian, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and United-Guardian wasn't on the list.

While United-Guardian currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines